EN − AZN
Anqiofluks 250 mg N50 Soft Capsules
-
5
1
-
4
0
-
3
0
-
2
0
-
1
0
Out Of Stock
Notify me when its in stockANGIOFLUKS, 250 LRU soft capsules
Angiofluks composition
Active ingredient: In 1 soft capsule there is 250 LRU (unit of lipoprotein lipase secretion activity) sulodexide. Excipients: Miglyol 812, sodium lauryl sulfate, precipitated silicon dioxide. gelatin, glycerol, ethyl p-hydroxybenzoate sodium, propyl p-hydroxybenzoate sodium, red iron oxide (E172).
Indications:
Chronic venous ulcers.
Contraindications:
High sensitivity to any of the active or excipient substances contained in the preparation. - Since the molecular structure is similar to heparin, ANGIOFLUKS should not be prescribed to patients with high sensitivity to heparin or heparinoids. - Hemorrhagic diathesis.
Use during pregnancy and lactation:
During pregnancy, treatment with this preparation is recommended only in cases of acute necessity and under medical supervision. Although studies on fetal toxic effects have shown that there is no embryo-fetal toxic effect, the use of the preparation during pregnancy is not recommended.
Angiofluks method of use, dosage
Take 1 capsule twice daily after meals. It is recommended to start treatment with intramuscular injections for 15–20 days, and then continue with capsules for 30–40 days. The course of treatment should be carried out at least twice a year. Depending on the doctor’s prescription, the dose amount and frequency may be changed.